Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells

Certain white blood cells in the immune system, known as neutrophils, can make cancer immunotherapy less effective, according to a new study from Karolinska Institutet published in the journal Immunity. The results show that a signaling molecule in the tumor affects neutrophils, reducing the effect of treatment.